Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
8 studies found for:    4337382 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Effect of Ginseng in Type 2 Diabetes
Condition: Type II Diabetes Control
Interventions: Dietary Supplement: CNT 2000 American ginseng extract;   Dietary Supplement: Placebo
2 Not yet recruiting The Effects of Consuming Palm Oil With Different Macronutrient Intakes on Blood Lipids
Conditions: Cardiovascular Diseases;   Inflammation
Interventions: Other: Canola Oil;   Other: Palm Oil;   Other: Butter
3 Not yet recruiting Hypolipidemic and Antioxidant Capacity of Spirulina and Exercise
Condition: Cardiovascular Diseases
Interventions: Dietary Supplement: Supplementation with Spirulina maxima;   Other: Washout;   Other: Supplementation with placebo;   Other: Isoenergetic diet;   Other: Exercise program
4 Active, not recruiting Nuts and Olestra for Persistent Organic Pollutant Reduction (NO-POPs) Trial
Conditions: Persistent Organic Pollutants;   Endocrine Disrupting Chemicals;   Endocrine Disruptor Effects
Interventions: Other: Whole Nuts;   Other: Olestra: Fat Free Pringles;   Other: Vegetable Oil: Original Pringles
5 Completed Conjugated Linoleic Acid in Obese Women
Conditions: Lipid Metabolism Disorders;   Obesity
Interventions: Dietary Supplement: CLA;   Behavioral: Placebo
6 Active, not recruiting Canola-Mediterranean Diet Study in T2DM
Conditions: Type 2 Diabetes;   Obesity;   Overweight;   Cardiovascular Diseases
Interventions: Behavioral: A canola oil enriched mediterranean diet;   Behavioral: A high wheat fiber diet
7 Completed
Has Results
Effects of Pravastatin on Cholesterol, Inflammation and Cognition in Schizophrenia
Conditions: Schizophrenia;   Schizoaffective Disorders;   Schizophreniform Disorders
Interventions: Drug: Pravastatin;   Drug: Placebo
8 Completed
Has Results
Ramelteon as an Adjunct Therapy in Non-Diabetic Patients With Schizophrenia
Conditions: Schizophrenia;   Schizoaffective Disorder;   Schizophreniform Disorders
Interventions: Drug: Ramelteon;   Drug: Placebo

Indicates status has not been verified in more than two years